Abstract:Five-year survival rate of patients with maxillary malignant neoplasms is low, the prognostic factors of these neoplasms were unclear. This study was to investigate prognostic factors of maxillary sinus malignant neoplasms.Records of 151 inpatients with malignant neoplasms of maxillary sinus initially treated at Cancer Center of Sun Yat-sen University from Sep. 1983 to Mar. 1999 were reviewed. Of 151 cases, 72 were squamous cell carcinoma (SCC), 44 were adenocarcinoma, 16 were sarcoma, and 19 were other histological types; according to 1997 UICC classification, 7 were stage II, 55 were stage III, and 89 were stage IV; 66 patients received combined therapy of surgery and radiotherapy, 14 received surgery alone, 25 received radiotherapy alone, 39 received other treatments, and 7 gave up treatment. All patients were followed up for more than 5 years. Influences of clinicopathologic factors on prognosis of patients with maxillary sinus malignant neoplasms were analyzed by Kaplan-Meier method, and Cox regression model with SPSS10.0 software.Five-year overall survival rate of patients of </=40 years old was 55.7%, that of patients of >40 years old was 33.3%(P=0.030); that of patients with SCC was 30.2%, of patients with adenocarcinoma was 57.5%, of patients with sarcoma was 24.3%, of patients with tumor of other histological types was 50.7% (P=0.011); that of patients with tumor of stage II, III, and IV were 85.7%, 45.8%, and 32.7%, respectively (P=0.029); that of patients with cervical metastases was 14.4%, of patients without cervical metastases was 44.1% (P=0.005); that of patients with distant metastases was 14.3%, of patients without distant metastases was 41.1% (P=0.011); that of patients without treatment was 14.3%, of patients treated with surgery alone was 42.9%, of patients treated with radiotherapy alone was 32.3%, of patients treated with combined therapy of surgery and radiotherapy was 50.8%, of patients treated with other treatments was 29.1% (P=0.004). Univariate survival analysis showed that the above 6 factors were prognostic factors of patients with maxillary sinus malignant neoplasms. Multivariate analysis showed that combination of surgery and radiotherapy (P=0.004, OR< 1), clinical stage (P=0.025, OR >1), SCC (P=0.016, OR >1), and sarcoma (P=0.003, OR >1) were independent prognostic factors of patients with maxillary sinus malignant neoplasms.For maxillary sinus malignant neoplasms, patients with SCC or sarcoma had poorer survival than patients with adenocarcinoma or other histological types of tumor; patients with sarcoma had poorer survival than patients with SCC. The higher the patient's clinical stage was, the worse his prognosis was. Combination of surgery and radiotherapy may be the best treatment for patients with maxillary sinus malignant neoplasms.

Therapeutic Outcome and Prognostic Factors in Sinonasal Rhabdomyosarcoma: a Single-Institution Case Series

Oncological Outcome of Patients with Salivary Gland Cancer Treated with Surgery and Postoperative Intensity-Modulated Radiotherapy: a Retrospective Study

Treatment Outcomes and Prognostic Factors of Adult Sinonasal Sarcomas: A Single-Institution Case Series

Clinical Characteristics and Prognosis of Childhood Rhabdomyosarcoma: a Ten-Year Retrospective Multicenter Study.

Outcome for sinonasal malignancies: a population-based survey

Prognostic Indicators for Salvage Surgery of Recurrent Sinonasal Malignancy

Nomogram to predict prognosis of head and neck rhabdomyosarcoma patients in children and adolescents

Radiotherapy Significantly Improves Long-Term Survival and Local Control of Head and Neck Rhabdomyosarcoma (HNRMS) in Adults: Retrospective Analysis of 64 Patients

[Retrospective study of 70 cases with the head and neck non-parameningeal rhabdomyosarcoma]

Clinical features and prognostic factors in children with rhabdomyosarcoma: a retrospective cohort study of 168 cases

Prognostic Factors in Patients with Rhabdomyosarcoma Using Competing-Risks Analysis: A Study of Cases in the SEER Database

Oncologic Outcomes of Surgical Treatments of Advanced Sinonasal Malignancies

Oncologic Outcome of Multimodality Treatment for Sinonasal Malignancies: an 18-Year Experience

Prognostic factors in sinonasal cancers: A multicenter pooled analysis.

Survival Outcomes and Prognostic Factors of Squamous Cell Carcinomas Arising from Sinonasal Inverted Papillomas: a Retrospective Analysis of 120 Patients

Treatment of nasolabial fold rhabdomyosarcoma in children: A single‐institution experience

Efficacy and Influencing Factors of Surgery Combined with Neoadjuvant Chemoradiotherapy in the Treatment of Children with Non-Orbital Head and Neck Rhabdomyosarcoma

Treatment for SMARCB1 (INI-1) deficient sinonasal tumor: a single-institution study

Real-Life Prognosis of Sinonasal Tumors

Treatment strategy and long-term outcomes of primary intracranial rhabdomyosarcoma: a single-institution experience and systematic review

Prognostic Analysis of 151 Patients with Maxillary Sinus Malignant Neoplasms